ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

DAVI vs XTNT // FORWARD P/E MULTIPLE

Davion Healthcare Plc (NASDAQ) VS. Xtant Medical Holdings Inc. (NYSE) • 15-METRIC TALLY: DAVI 1 — XTNT 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DAVI VS. XTNT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC DAVI XTNT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 62.90% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — 12.80% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — 3.7x — TIE /valuation <GO>
Free Cash Flow Yield — 24.95% — TIE /fcf-yield <GO>
Operating Margin — 5.40% — TIE /operating-margins <GO>
Net Profit Margin — 0.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — 14.20% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality — 9/9 — TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 18.0 37.2 -19.20 XTNT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $42.0M $39.3M $2.7M DAVI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR DAVI REV XTNT REV DAVI GROSS % XTNT GROSS % DAVI FCF XTNT FCF
FY 2025 — $133.9M — 62.9% — $10.2M
FY 2024 — $117.3M — 58.2% — -$16.0M
FY 2023 — $91.3M — — — -$9.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DAVI // BETA —
XTNT // BETA —